Search research articles
Contact Us
Filters
Showing results (101-110 of 147) with videos related to
Page
of 15
Sort By:
JAMA Oncology
|
December 29, 2022
Association of COVID-19 Vaccination With Breakthrough Infections and Complications in Patients With Cancer
Inna Y Gong, Abi Vijenthira, Melanie Powis, et al.
Value in Health : the Journal of the International Society for Pharmacoeconomics and Outcomes Research
|
September 29, 2024
Cancer Drug Wastage and Mitigation Methods: A Systematic Review
Krishna Sabareesh Rajangom, F Safa Erenay, Qi-Ming He, et al.
The Oncologist
|
June 12, 2025
The Association of Health Care Contact Days with Economic Measures in the CCTG LY.12 Trial
Arjun Gupta, Tyler Thomas, Annette E Hay, et al.
Current Oncology (Toronto, Ont.)
|
December 23, 2021
Delivery of Virtual Care in Oncology: Province-Wide Interprofessional Consensus Statements Using a Modified Delphi Process
Matthew C Cheung, Bryan B Franco, Nicholas Meti, et al.
Blood Advances
|
January 29, 2026
Pediatric-Inspired Regimens & HSCT for Adolescents & Young Adults with Acute Lymphoblastic Leukemia: Systematic Reviews
Yuliia Sereda, Htun Ja Mai, Ghid Kanaan, et al.
British Journal of Haematology
|
August 29, 2025
Outcomes following exposure to drug interactions with ibrutinib in patients with chronic lymphocytic leukaemia
Tuan Hoang, Matthew C Cheung, David N Juurlink, et al.
Current Oncology (Toronto, Ont.)
|
April 3, 2021
Evaluating the Indirect Costs of Care Associated with Salvage Chemotherapy for Relapsed and Refractory Aggressive-Histology Lymphoma: A Subset Analysis of the Canadian Cancer Trials Group (CCTG) LY.12 Clinical Trial
Anca Prica, Annette E Hay, Michael Crump, et al.
Journal of the National Comprehensive Cancer Network : JNCCN
|
December 6, 2019
Are Surrogate Endpoints Unbiased Metrics in Clinical Benefit Scores of the ASCO Value Framework?
Sierra Cheng, Matthew C Cheung, Di Maria Jiang, et al.
Current Oncology (Toronto, Ont.)
|
April 3, 2021
A Canadian Prospective Study of Linkage of Randomized Clinical Trial to Cancer and Mortality Registry Data
Annette E Hay, Nicole Mittmann, Michael Crump, et al.
Hematological Oncology
|
May 1, 2018
Management of newly diagnosed high-risk and intermediate-risk follicular lymphoma with <sup>90</sup> Y ibritumomab tiuxetan in a phase II study
Neil L Berinstein, Nancy M Pennell, Rashmi Weerasinghe, et al.
Page
of 15
Search research articles
Search
Showing results (101-110 of 147) with videos related to
Sort By:
Page
of 15
JAMA Oncology
|
December 29, 2022
Association of COVID-19 Vaccination With Breakthrough Infections and Complications in Patients With Cancer
Inna Y Gong, Abi Vijenthira, Melanie Powis, et al.
Value in Health : the Journal of the International Society for Pharmacoeconomics and Outcomes Research
|
September 29, 2024
Cancer Drug Wastage and Mitigation Methods: A Systematic Review
Krishna Sabareesh Rajangom, F Safa Erenay, Qi-Ming He, et al.
The Oncologist
|
June 12, 2025
The Association of Health Care Contact Days with Economic Measures in the CCTG LY.12 Trial
Arjun Gupta, Tyler Thomas, Annette E Hay, et al.
Current Oncology (Toronto, Ont.)
|
December 23, 2021
Delivery of Virtual Care in Oncology: Province-Wide Interprofessional Consensus Statements Using a Modified Delphi Process
Matthew C Cheung, Bryan B Franco, Nicholas Meti, et al.
Blood Advances
|
January 29, 2026
Pediatric-Inspired Regimens & HSCT for Adolescents & Young Adults with Acute Lymphoblastic Leukemia: Systematic Reviews
Yuliia Sereda, Htun Ja Mai, Ghid Kanaan, et al.
British Journal of Haematology
|
August 29, 2025
Outcomes following exposure to drug interactions with ibrutinib in patients with chronic lymphocytic leukaemia
Tuan Hoang, Matthew C Cheung, David N Juurlink, et al.
Current Oncology (Toronto, Ont.)
|
April 3, 2021
Evaluating the Indirect Costs of Care Associated with Salvage Chemotherapy for Relapsed and Refractory Aggressive-Histology Lymphoma: A Subset Analysis of the Canadian Cancer Trials Group (CCTG) LY.12 Clinical Trial
Anca Prica, Annette E Hay, Michael Crump, et al.
Journal of the National Comprehensive Cancer Network : JNCCN
|
December 6, 2019
Are Surrogate Endpoints Unbiased Metrics in Clinical Benefit Scores of the ASCO Value Framework?
Sierra Cheng, Matthew C Cheung, Di Maria Jiang, et al.
Current Oncology (Toronto, Ont.)
|
April 3, 2021
A Canadian Prospective Study of Linkage of Randomized Clinical Trial to Cancer and Mortality Registry Data
Annette E Hay, Nicole Mittmann, Michael Crump, et al.
Hematological Oncology
|
May 1, 2018
Management of newly diagnosed high-risk and intermediate-risk follicular lymphoma with <sup>90</sup> Y ibritumomab tiuxetan in a phase II study
Neil L Berinstein, Nancy M Pennell, Rashmi Weerasinghe, et al.
Page
of 15